Voyageur Pharmaceuticals Ltd
Research Voyageur Pharmaceuticals Ltd (VM) on Bullrun: market cap CAD 35.08M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVM
- ExchangeV
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyCAD
- Market capCAD 35.08M
- Financial periodQ2 2026
- RevenueCAD 16.28K
- Net income-CAD 996.99K
- Free cash flowCAD 405.21K
- Gross margin0.0%
Valuation Snapshot
latest market cap is CAD 35.08M.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | CAD 35.08M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CAD.
About Voyageur Pharmaceuticals Ltd
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Voyageur Pharmaceuticals Ltd's market cap?
Voyageur Pharmaceuticals Ltd's market capitalization is CAD 35.08M.
What does Voyageur Pharmaceuticals Ltd do?
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The company has a collaboration with Bayer for the research and development of evaluating potential future production of iodine to be used in contrast media drugs. Voyageur Pharmaceuticals Ltd.